NLRP3 and lung carcinoma: In lung cancer, Liu J et al. demonstrated that ROS generation contributes to NLRP3 activation [41], and Zhu M et al. reported that GSDMD initiation was driven by ROS acceleration, both of which ultimately resulted in pyroptotic cell death [42].